NHI
National Health Investors, Inc.
NYSE · Real Estate · REIT - Healthcare Facilities · US
$71.06
−1.18%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 433.6M | 378.5M | 335.2M | 319.8M | 278.2M |
| Cost of Revenue | 153.2M | 239.6M | 11.2M | 11.5M | 9.8M |
| Gross Profit | 280.4M | 138.9M | 324.0M | 308.3M | 268.4M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 15.3M | — | 21.8M | 19.8M | 25.3M |
| General & Admin Expense | 15.3M | — | 21.8M | 19.8M | 25.3M |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 68.1M | (55.9M) | 118.4M | 109.7M | 110.3M |
| Total Operating Expenses | 83.4M | (55.9M) | 140.2M | 129.5M | 135.6M |
| Cost and Expenses | 236.5M | 183.7M | 151.3M | 141.0M | 145.4M |
| Operating Income (EBIT) | 197.0M | 194.8M | 183.9M | 178.8M | 132.8M |
| Non-Operating | |||||
| Interest Income | 4.9M | 23.8M | — | (2.6M) | — |
| Interest Expense | 44.2M | 57.4M | 56.1M | 55.5M | 42.4M |
| Net Interest Income | (39.3M) | (33.6M) | (56.1M) | (58.2M) | (42.4M) |
| Other Non-Op Income/Expense | (30.9M) | (54.0M) | (47.3M) | (44.4M) | (67.4M) |
| Non-Operating Income (excl Interest) | (26.4M) | (3.3M) | (8.9M) | (11.1M) | 24.9M |
| EBT (Pre-Tax Income) | 166.1M | 140.8M | 136.6M | 134.4M | 65.4M |
| Income Tax Expense | 732.0K | — | (45.0K) | — | (89.0K) |
| Bottom Line | |||||
| Net Income | 166.8M | 142.2M | 138.0M | 135.7M | 66.4M |
| Earnings from Cont. Ops | 165.4M | 140.8M | 136.6M | 134.4M | 65.5M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 166.6M | 142.2M | 137.9M | 135.6M | 66.4M |
| Per Share | |||||
| Basic EPS | $3.47 | $3.03 | $3.14 | $3.13 | $0.52 |
| Diluted EPS | $3.46 | $3.02 | $3.13 | $3.13 | $0.51 |
| Revenue Per Share | $8.95 | $8.08 | $7.64 | $7.37 | $6.21 |
| Shares | |||||
| Basic Shares Outstanding | 48.4M | 46.9M | 43.8M | 43.4M | 44.8M |
| Diluted Shares Outstanding | 48.5M | 47.1M | 44.1M | 43.4M | 44.8M |
| Profitability Metrics | |||||
| EBITDA | 316.0M | 282.0M | 264.2M | 259.9M | 178.7M |
| D&A | 92.6M | 83.8M | 71.4M | 70.0M | 70.9M |
| EBIT | 223.4M | 198.2M | 192.7M | 189.9M | 107.9M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026